FDA Inspection
Wyeth Pharmaceuticals LlcWyeth Pharmaceuticals Llc – FDA Inspection, Jun 6, 2013
Record Details
This FDA Inspection record concerns Wyeth Pharmaceuticals Llc, with an inspection on June 6, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Wyeth Pharmaceuticals Llc
- Inspection Date
- June 6, 2013
- Product Type
- Drugs
View Company Profile
ID · cb0eda6f-7ce2-401f-9e92-cc3bbc286267
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 834523
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.56(b)Investigator non-compliance
- 21 CFR 312.56(a)Monitoring investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Wyeth Pharmaceuticals Llc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| April 7, 2026 | Not classified | Philadelphia District Office | |
| August 29, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 15, 2013 | NAI | Center for Drug Evaluation and Research | Prescription Drug Advertising and Labelling |
| June 24, 2010 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Wyeth Pharmaceuticals Llc
- FDA Inspection 1302588 - 2026-04-07
- FDA Inspection 1031032 - 2017-08-29
- FDA Inspection 844357 - 2013-08-15
- FDA Inspection 668809 - 2010-06-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.